Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40763476	s-rapim1e	u/ml (—)	184	195	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Adverse effects, not elsewhere classified

41.35

136.01

1.0

1.1

—

Other and unspecified effects of external causes

24.85

119.48

1.0

1.1

—

Other medical care

13.79

49.85

1.1

—

Toxic effects of substances chiefly nonmedicinal as to source

68.10

47.14

1.1

1.0

—

Desensitization to allergens

62.48

42.32

1.1

1.3

—

Allergic rhinitis

12.14

37.86

1.1

—

Urticaria and erythema

8.32

33.78

1.1

—

Urticaria

8.93

33.28

1.1

—

Pollen allergy

11.42

28.69

1.1

—

Vasomotor and allergic rhinitis

7.71

28.64

1.1

—

Contact with other specified venomous animals

+∞

23.29

1.0

0.0

—

Asthma and allergy

41.21

20.29

1.0

—

Asthma and allergy, excluding more controls

24.74

18.06

1.0

—

Asthma (mode)

4.68

16.60

1.0

1.1

—

Asthma (only as main-diagnosis)

4.74

16.35

1.0

1.1

—

Persons encountering health services for specific procedures and health care

110

3.49

16.22

1.1

1.0

—

Asthma (only as main-diagnosis), excluding more controls

4.68

16.05

1.0

1.1

—

Allergic asthma (mode)

13.24

15.72

1.1

—

Allergic asthma (mode), excluding more controls

13.23

15.72

1.1

—

Asthma

4.39

14.74

1.0

1.1

—

Unspecified privation

18.41

14.66

1.2

1.0

—

Asthma, excluding more controls

4.36

14.63

1.0

1.1

—

Asthma (diagnoses ohter than nonallergic)

123

3.31

12.80

1.0

1.1

—

Asthma, hospital admissions , main diagnosis only

129

3.21

11.97

1.0

1.1

—

Other and unspecified urticaria

9.22

11.46

1.1

—

Exposure to unspecified factor

131

2.91

10.88

1.1

—

Other diseases of upper respiratory tract

3.22

10.84

1.0

1.1

—

Atopic dermatitis

3.38

10.83

1.0

1.1

—

Chronic diseases of tonsils and adenoids

3.40

10.60

1.0

1.1

—

Dermatitis and eczema

124

2.70

9.34

1.1

1.0

—

Asthma, including avohilmo

121

2.60

8.79

1.0

—

Pain in joint

3.51

8.77

1.0

1.1

—

Exposure to other specified factors

128

2.87

8.60

1.1

1.0

—

Other external causes of accidental injury

3.67

8.53

1.1

1.0

—

Mastocytosis

+∞

8.39

1.0

0.0

—

Allergic urticaria

13.04

7.87

1.0

—

Examination and observation for other reasons

3.60

7.49

1.1

—

Special screening examination for infectious and parasitic diseases

4.34

7.35

1.0

1.1

—

Other and unspecified vaccines and biological substances

+∞

7.32

1.0

0.0

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

20.12

7.13

1.0

—

Accidents

3.34

6.88

1.1

1.0

—

Other and unspecified dermatitis

3.29

6.67

1.0

1.1

—

Transport accidents

3.99

6.65

1.0

—

Dermatitis

2.97

6.58

1.0

1.1

—

Chronic lower respiratory diseases

122

2.31

6.57

1.0

1.1

—

Diseases of the skin and subcutaneous tissue

2.64

6.34

1.1

—

Other congenital malformations of skin

15.07

5.90

1.0

—

Asthma/COPD (KELA code 203)

122

2.36

5.87

1.1

—

Other specific joint derangements/joint disorders

2.53

5.71

1.0

—

Asthma-related infections

2.98

5.67

1.0

1.1

—

Asthma, hospital admission 2, infections

2.98

5.67

1.0

1.1

—

Migraine with aura

3.70

5.63

1.1

—

3.21

5.63

1.0

—

Medical observation and evaluation for suspected diseases and conditions

3.07

5.57

1.0

1.1

—

Asthma, unspecified (mode)

3.30

5.47

1.0

1.1

—

Atopic dermatitis, strict definition with reimbursement

3.34

5.39

1.0

1.1

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

9.11

5.28

1.0

—

Asthma, unspecified (mode), excluding more controls

3.21

5.25

1.0

1.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

4.45

5.04

1.0

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3.08

5.04

1.0

1.1

—

Other congenital malformations of skin

10.02

5.02

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

112

2.20

5.02

1.1

1.0

—

Oral corticosteroids

116

2.20

5.00

1.1

1.0

—

Deviated nasal septum

5.00

4.92

1.1

—

Atopic dermatitis, strict definition

3.21

4.84

1.0

1.1

—

Other congenital malformations

7.51

4.35

1.0

1.2

—

Opioids

100

2.13

4.31

1.0

—

Pain in limb

2.30

4.30

1.0

1.1

—

Other/unspecified dorsalgia

3.31

4.25

1.1

1.0

—

Allergic conjunctivitis

117

2.33

4.20

1.0

1.1

—

Tramadol

2.32

4.16

1.1

1.0

—

ILD medications

114

2.05

4.15

1.1

1.0

—

Tonsillectomy and adenotomy

2.25

4.01

1.1

1.0

—

Soft tissue disorders

103

2.05

3.94

1.1

—

Disturbances of skin sensation

3.13

3.92

1.2

1.1

—

First line medication for Crohn's disease

113

2.01

3.89

1.1

1.0

—

Injuries to the hip and thigh

3.02

3.87

1.1

—

Other soft tissue disorders, not elsewhere classified

100

2.11

3.86

1.0

1.1

—

Other disorders of patella

5.27

3.82

1.1

—

Dermatographic urticaria

8.77

3.77

1.0

—

Sciatica+with lumbago

2.54

3.76

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

114

2.08

3.75

1.0

1.1

—

Triptan medication for migraine, single purchase ok

114

2.08

3.75

1.0

1.1

—

Fracture of lower leg, including ankle

2.50

3.70

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

112

2.26

3.66

1.0

1.1

—

Superficial injury of ankle and foot

5.63

3.65

1.1

—

Other congenital malformations

5.63

3.65

1.0

1.1

—

External causes of morbidity and mortality

3.01

3.64

1.1

1.0

—

Conjunctivitis

134

2.06

3.61

1.0

1.1

—

Migraine

2.27

3.57

1.1

—

Herpesviral [herpes simplex] infections

6.16

3.50

1.0

—

Allergic contact dermatitis

6.16

3.50

1.0

—

Candidiasis

6.16

3.50

1.0

—

Sequelae of other external causes

10.02

3.50

1.0

—

Infective dermatitis

10.01

3.49

1.0

—

Obesity related asthma

3.61

3.49

1.0

1.1

—

Other joint disorders

2.01

3.45

1.1

1.0

—

Complications of medical and surgical care

115

2.16

3.41

1.1

1.0

—

Acute pharyngitis

4.51

3.40

1.0

1.1

—

Inflammatory bowel disease treatment related agents

124

1.89

3.38

1.0

—

Other disorders of veins

2.74

3.37

1.1

1.0

—

Soft tissue disorders related to use, overuse and pressure

5.00

3.36

1.1

1.0

—

Fibromyalgia

8.58

3.26

1.2

1.0

—

Rotator cuff syndrome

2.52

3.20

1.1

—

Ventral hernia

4.17

3.19

1.1

1.0

—

Chronic sinusitis

2.73

3.14

1.0

1.1

—

Disorders of conjunctiva

136

1.95

3.13

1.0

1.1

—

Internal derangement of knee

2.72

3.12

1.1

—

Injury, poisoning and certain other consequences of external causes

3.19

3.11

1.0

—

Injuries to the knee and lower leg

135

1.81

3.11

1.1

1.0

—

Trochanteric bursitis

7.51

3.05

1.0

—

Dorsalgia

100

1.93

3.05

1.0

—

Other inflammation of eyelid

5.84

3.02

1.3

1.0

—

Radiculopathy

5.84

3.02

1.3

1.0

—

Type of accident

3.34

3.01

1.0

1.1

—

Mycoses

3.55

2.98

1.0

1.1

—

Metatarsalgia

10.01

2.98

1.0

—

Other enthesopathy of foot (+metatarsalgia)

10.01

2.98

1.0

—

Other bursopathies

10.01

2.98

1.0

—

Triptan medication for migraine, min. 3 purchases

105

2.04

2.98

1.0

1.1

—

Other fall from one level to another

3.85

2.97

1.3

1.0

—

Shoulder lesions

2.20

2.94

1.0

1.1

—

Tinnitus

4.09

2.88

1.2

1.0

—

Migraine with aura and triptan purchases

3.71

2.87

1.0

—

Other dorsopathies, not elsewhere classified

100

1.88

2.86

1.1

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2.36

2.84

1.0

1.1

—

Other intervertebral disc disorders

2.03

2.82

1.1

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

2.68

2.79

1.1

—

Cervicalgia

3.92

2.77

1.0

—

Other pulmonary diagnosis

2.19

2.75

1.2

1.1

—

Other obstetric trauma

8.35

2.75

1.2

1.0

—

Hordeolum and other deep inflammation of eyelid

8.35

2.75

1.0

—

Other disorders of breast

5.00

2.72

1.0

—

Other and unspecified disorders of vitreous body

3.03

2.72

1.0

—

Persons encountering health services for specific procedures, not carried out

6.01

2.70

1.0

1.2

—

Superficial injury of hip and thigh

6.00

2.69

1.0

—

Injuries to the ankle and foot

136

1.90

2.64

1.0

1.1

—

Gastro-oesophageal reflux disease

102

2.03

2.63

1.0

1.1

—

Superficial injury of abdomen, lower back and pelvis

4.67

2.59

1.4

1.0

—

Disorders of synovium and tendon

2.22

2.59

1.1

—

Overexertion and strenuous or repetitive movements

5.46

2.54

1.0

1.2

—

Other complications of surgical and medical care, not elsewhere classified

5.46

2.54

1.0

—

Nasal polyp

5.46

2.54

1.0

1.2

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

2.86

2.54

1.0

1.1

—

Glucagon-like peptide-1 (GLP-1) analogues

2.86

2.54

1.0

1.1

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2.86

2.54

1.0

1.1

—

Covid-19 confirmed case

2.73

2.54

1.0

1.1

—

Other headache syndromes

2.27

2.49

1.0

1.1

—

Dorsopathies

102

1.79

2.49

1.1

1.0

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

2.97

2.48

1.0

1.1

—

Sequelae of external causes of morbidity and mortality

3.46

2.48

1.0

1.1

—

Other enthesopathies

3.46

2.48

1.0

—

Impingement syndrome of shoulder

4.38

2.47

1.1

1.0

—

Coxarthrosis

2.57

2.42

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.13

2.42

1.2

1.0

—

Nonalcoholic fatty liver disease

5.01

2.40

1.0

—

Open wound of lower leg

5.00

2.40

1.2

—

Other arthrosis

2.36

2.38

1.0

1.1

—

Contusion of other and unspecified parts of foot

6.26

2.37

1.0

1.3

—

Lumbar disc prolapse

2.06

2.37

1.2

1.0

—

Fracture of foot, except ankle

3.03

2.35

1.0

1.1

—

Sequelae of injuries, of poisoning and of other consequences of external causes

3.22

2.30

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

130

1.88

2.30

1.1

—

Abnormalities of heart beat

2.45

2.26

1.2

1.1

—

Other diseases of liver

3.89

2.25

1.0

1.1

—

Recurrent aphthous stomatitis , including avohilmo

3.89

2.25

1.0

1.1

—

Spondyloarthritis

3.89

2.25

1.0

1.1

—

Disorders of vitreous body and globe

2.45

2.24

1.0

1.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

2.43

2.22

1.2

1.1

—

Event of undetermined intent

5.56

2.21

1.0

1.2

—

Other postsurgical states

5.56

2.21

1.2

1.0

—

Lower back pain or/and sciatica

139

1.69

2.20

1.1

—

Abnormalities of breathing

110

1.74

2.18

1.0

1.1

—

Other and unspecified nerve root and plexus disorders, also in other diseases

3.34

2.18

1.1

—

Peritonsillar abscess

3.33

2.18

1.0

1.1

—

Stomatitis and related lesions

3.34

2.17

1.0

1.1

—

Episodal and paroxysmal disorders

119

1.67

2.15

1.0

1.1

—

Early lumbar disc prolapse, operated

4.29

2.15

1.3

1.1

—

Early lumbar disc prolapse operation

4.29

2.15

1.3

1.0

—

Spondylopathies (FG)

4.29

2.15

1.0

1.1

—

Other disorders of eye and adnexa

4.29

2.15

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.62

2.14

1.0

—

Candidiasis

2.62

2.14

1.0

1.1

—

Migraine without aura

2.78

2.13

1.0

1.1

—

Codeine

100

1.74

2.08

1.1

1.0

—

Disorders of sclera, cornea, iris and ciliary body

2.02

2.05

1.1

—

Coeliac disease

4.00

2.04

1.0

—

Other nutritional deficiencies

132

1.78

1.97

1.0

1.1

—

Leisure time condition

3.34

1.96

1.0

1.1

—

Primary coxarthrosis, bilateral

3.33

1.96

1.0

—

Other blood glucose lowering drugs, excl. Insulins

4.55

1.94

1.0

—

Cervical disc disorders

2.56

1.94

1.1

—

Falls/tendency to fall

117

1.63

1.93

1.1

—

Antepartum haemorrhage, not elsewhere classified

3.75

1.93

1.0

—

Other condition

3.75

1.93

1.0

1.1

—

Non-allergic asthma (mode), excluding more controls

3.71

1.91

1.0

—

Non-allergic asthma (mode)

3.71

1.91

1.0

—

Childhood allergy (age < 16)

3.00

1.91

1.0

1.1

—

Open wound of wrist and hand

2.06

1.91

1.0

1.1

—

Mouth breathing

2.24

1.90

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.00

1.89

1.2

1.0

—

Nontoxic goitre/thyroid nodule

2.65

1.86

1.0

—

Other disorders of lacrimal gland

2.39

1.85

1.2

1.0

—

Superficial injury of forearm

4.17

1.82

1.0

1.2

—

Coxarthrosis [arthrosis of hip](FG)

2.19

1.82

1.0

1.1

—

Fracture of lumbar spine and pelvis

4.16

1.82

1.0

—

Excluding asthma or asthma-COPD overlap

1.91

1.81

1.1

—

COPD differential diagnosis

1.91

1.81

1.1

—

ILD differential diagnosis

1.91

1.81

1.1

—

Fenamates

3.70

1.80

1.0

—

Disorders of vestibular function (Vertigo)

2.27

1.80

1.0

1.1

—

Disorders of vitreous body

2.27

1.80

1.0

1.1

—

Nontoxic multinodular goitre

3.05

1.79

1.0

—

Other diseases of blood and blood-forming organs, wide

3.04

1.79

1.0

—

Headache

109

1.76

1.78

1.1

—

Hernia of abdominal wall

2.17

1.77

1.1

—

Benign neoplasm of other and ill-defined parts of digestive system

3.34

1.74

1.2

1.0

—

Acute suppurative otitis media

2.24

1.74

1.2

1.0

—

Other arrhythmias

1.77

1.73

1.0

1.1

—

Glaucoma suspect

2.50

1.73

1.0

—

Subjective visual disturbances

2.67

1.72

1.0

1.1

—

Benign paroxysmal vertigo

2.67

1.72

1.0

1.1

—

Excessive vomiting in pregnancy

3.85

1.71

1.0

—

Benign neoplasm of other and unspecified endocrine glands

3.85

1.71

1.0

—

Methotrexate

3.85

1.71

1.0

—

Fall on same level

138

1.54

1.67

1.0

1.1

—

Other functional intestinal disorders

2.12

1.66

1.0

1.1

—

Superficial injury of lower leg

2.58

1.65

1.0

1.1

—

Other noninfective gastroenteritis and colitis

2.58

1.65

1.0

1.1

—

Fall on same level involving ice and snow

1.86

1.65

1.0

1.1

—

Artificial joint operation, meniscal resection

1.73

1.65

1.0

1.1

—

Bronchitis

141

1.56

1.64

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

111

1.58

1.63

1.1

—

Disorders of continuity of bone

3.57

1.61

1.0

1.1

—

Fibroblastic disorders

3.57

1.61

1.0

—

Acute sinusitis

1.81

1.61

1.1

—

Concussion

1.86

1.61

1.1

—

Diseases of liver

2.38

1.61

1.1

—

Viral and other specified intestinal infections

2.38

1.61

1.1

1.0

—

Keratitis

2.14

1.60

1.1

—

Arthropathies

1.62

1.60

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.50

1.59

1.0

1.1

—

Voice disturbances

2.50

1.59

1.0

—

Anogenital herpesviral [herpes simplex] infection

3.00

1.58

1.0

1.1

—

Enthesopathies of lower limb, excluding foot

2.69

1.58

1.1

1.0

—

Otitis externa

2.69

1.58

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

111

1.74

1.58

1.2

1.0

—

Infections with a predominantly sexual mode of transmission

1.86

1.57

1.0

—

Acute upper respiratory infections

125

1.58

1.56

1.1

—

Heart failure and coronary heart disease

0.00

1.56

0.0

1.0

—

Puerperal sepsis

3.34

1.52

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

112

1.65

1.52

1.1

—

Other neurological diseases

1.86

1.51

1.1

—

Cervicobrachial syndrome

2.59

1.51

1.1

1.0

—

Obesity due to excess calories

1.83

1.51

1.1

—

Artrosis, including avohilmo

1.64

1.51

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at neck level

2.86

1.50

1.0

1.1

—

Codes for special purposes

1.86

1.49

1.0

1.1

—

Provisional assignment of new diseases of uncertain etiology

1.86

1.49

1.0

1.1

—

Sleep apnoea

113

1.60

1.48

1.0

1.1

—

Nerve, nerve root and plexus disorders

126

1.56

1.48

1.0

1.1

—

Excessive attrition of teeth

116

1.72

1.48

1.0

1.1

—

Meniscus derangement

1.94

1.47

1.0

1.1

—

Recurrent or chronic depression

1.81

1.46

1.1

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

1.73

1.46

1.0

1.1

—

Arthrosis

1.77

1.44

1.0

1.1

—

Bitten or struck by other mammals

3.13

1.44

1.2

1.1

—

Intracranial injury

1.79

1.40

1.1

1.0

—

Herpesviral [herpes simplex] infections

2.17

1.39

1.0

1.1

—

Coxarthrosis, primary

2.03

1.39

1.0

—

Sleep apnoea, including avohilmo

120

1.55

1.38

1.0

1.1

—

Obesity, other/unspecified

1.94

1.38

1.0

1.1

—

Low back pain

1.66

1.37

1.0

—

Other systemic involvement of connective tissue (FG)

2.38

1.36

1.1

1.0

—

Diseases of inner ear

1.93

1.36

1.0

1.1

—

Pain in thoracic spine

2.94

1.36

1.2

1.0

—

Diseases of external ear

2.14

1.33

1.0

1.1

—

Disturbance of activity and attention

2.56

1.33

1.0

1.1

—

117

1.50

1.33

1.0

1.1

—

Crowding of teeth, including avohilmo

2.95

1.33

1.0

—

Papulosquamous disorders

2.04

1.32

1.0

1.1

—

Striking against or struck by other objects

2.04

1.32

1.2

1.0

—

Obesity and other hyperalimentation

131

1.62

1.31

1.0

1.1

—

Hernia of abdominal wall, postoperative

2.50

1.30

1.2

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

2.50

1.30

1.0

—

Ganglion

2.50

1.30

1.0

1.1

—

Injuries to the shoulder and upper arm

122

1.58

1.29

1.0

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1.96

1.27

1.1

1.0

—

Disorders of lacrimal system

1.93

1.26

1.2

1.0

—

General symptoms and signs

119

1.47

1.26

1.0

1.1

—

Malaise and fatigue

1.85

1.26

1.1

—

COPD/asthma related infections

111

1.49

1.25

1.0

1.1

—

COPD/asthma/ILD related infections

111

1.49

1.25

1.0

1.1

—

2.72

1.24

1.0

—

Abrasion of teeth

2.04

1.21

1.0

1.1

—

Lichen planus, including avohilmo

2.63

1.21

1.0

—

Other symptoms and signs involving the digestive system and abdomen

2.63

1.21

1.0

—

Infections of the skin and subcutaneous tissue

107

1.67

1.21

1.0

1.1

—

Viral and other specified intestinal infections

1.97

1.21

1.1

—

Hyperkinetic disorders

2.35

1.21

1.0

1.1

—

Cough

1.96

1.20

1.0

1.1

—

Certain conditions originating in the perinatal period

2.61

1.19

1.0

—

Dysphagia

2.31

1.18

1.0

—

Conjunctivitis (acute, non atopic)

2.10

1.18

1.0

1.1

—

Intracranial trauma

1.65

1.17

1.1

1.0

—

Spondylolisthesis/Spondylolysis

2.50

1.15

1.0

1.1

—

Dental pulpitis, including avohilmo

138

1.46

1.14

1.0

1.1

—

Carpal tunnel syndrome

1.66

1.13

1.1

—

Umbilical hernia

2.33

1.12

1.1

—

Obesity

130

1.56

1.11

1.0

1.1

—

Other diseases of anus and rectum

2.25

1.10

1.0

1.1

—

Impacted teeth

1.98

1.09

1.0

1.1

—

Cardiac arrhythmias

1.54

1.09

1.0

1.1

—

Symptoms and signs involving speech and voice

1.95

1.08

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

142

1.44

1.08

1.0

1.1

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

2.19

1.08

1.0

—

Asthma-related pneumonia

2.18

1.07

1.0

1.1

—

Asthma, hospital admissions 3, pneumonia

2.18

1.07

1.0

1.1

—

Asthma-related pneumonia or sepsis

2.18

1.07

1.0

1.1

—

Diseases of the respiratory system

1.80

1.07

1.1

—

Pure hypercholesterolaemia

1.66

1.06

1.1

—

Solid cancers, helper endpoint

115

0.56

1.06

1.0

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

1.74

1.05

1.1

—

Migraine without aura and triptan purchases

2.12

1.05

1.0

1.1

—

Use of pramipexole

2.27

1.03

1.0

—

Polyuria

2.27

1.03

1.0

—

Cellulitis

2.27

1.03

1.0

1.1

—

Other systemic involvement of connective tissue

2.06

1.02

1.1

1.0

—

Fever of other and unknown origin

1.64

1.02

1.1

—

Diaphragmatic hernia

2.00

1.00

1.0

—

Diseases of the digestive system

1.88

0.99

1.0

1.1

—

Polycystic ovarian syndrome, consortium definition

113

0.58

0.99

1.1

1.0

—

Iridocyclitis

2.17

0.98

1.0

1.1

—

Codeine or tramadol medication

134

1.39

0.97

1.1

1.0

—

Primary gonarthrosis, bilateral

1.86

0.95

1.0

—

Diverticular disease of intestine

1.60

0.94

1.1

—

Transient ischemic attack

1.78

0.94

1.1

1.0

—

Dizziness and giddiness

111

1.50

0.94

1.1

1.0

—

Malignant neoplasm, wide definition for exclusion

124

0.61

0.93

1.0

1.1

—

Other viral diseases, not elsewhere classified

1.72

0.91

1.2

1.1

—

Panic disorder

2.14

0.91

1.0

—

Fall on and from stairs and steps

2.14

0.91

1.2

1.1

—

Malignant neoplasm

117

0.61

0.91

1.0

1.1

—

Gonarthrosis

1.64

0.91

1.1

1.0

—

Spondylopathies

1.56

0.91

1.1

1.0

—

Degeneration of macula and posterior pole

1.93

0.89

1.0

—

Pedal cyclist injured in transport accident

2.07

0.89

1.0

1.1

—

Cerebrovascular diseases (FINNGEN)

1.77

0.88

1.3

1.1

—

Appendectomy

137

1.47

0.88

1.1

—

Liquid cancers, helper endpoint

1.89

0.88

1.0

1.1

—

Caries of enamel

145

1.39

0.87

1.0

1.1

—

Disorders of eyelid, lacrimal system and orbit

121

1.44

0.87

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.53

0.86

1.2

1.0

—

Emergency coronary revascularization (for ACS)

0.56

0.86

1.0

1.1

—

Hyperkinetic disorders, excluding more controls

1.98

0.86

1.0

—

Complications of surgical and medical care, not elsewhere classified

138

1.39

0.85

1.1

—

Spontaneous abortion

0.51

0.85

1.2

1.0

—

Zoster [herpes zoster]

1.76

0.83

1.0

1.1

—

Complications predominantly related to the puerperium

1.75

0.83

1.0

—

Injuries to the elbow and forearm

113

1.48

0.83

1.0

1.1

—

Injuries to the neck

1.88

0.81

1.0

1.1

—

All influenza

1.87

0.81

1.0

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

148

0.65

0.81

1.0

1.1

—

Unspecified fall

1.64

0.81

1.0

1.1

—

Diseases of oesophagus, stomach and duodenum

127

1.37

0.80

1.0

1.1

—

Intestinal infectious diseases

141

1.34

0.79

1.1

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

0.79

0.0

1.1

—

Mycoses

157

1.38

0.79

1.1

—

Hypertrophy of breast in women and men

1.82

0.79

1.0

—

Urolithiasis

1.82

0.79

1.0

1.1

—

Haemorrhoids and perianal venous thrombosis

1.81

0.79

1.0

1.1

—

Polycystic ovarian syndrome, broad definition

0.00

0.77

0.0

1.0

—

Deforming dorsopathies

1.77

0.76

1.0

—

Coronary revascularization (ANGIO or CABG)

0.59

0.76

1.0

1.1

—

Percutaneous Coronary Intervention

0.59

0.76

1.0

1.1

—

Metabolic disorders

110

1.39

0.76

1.0

1.1

—

Spondylosis

1.66

0.75

1.1

1.0

—

Explicit Sepsis

1.68

0.75

1.0

1.1

—

Complications of procedures, not elsewhere classified

130

1.40

0.74

1.1

—

Propionic acid derivatives

1.85

0.74

1.3

1.0

—

Psoriasis

1.84

0.73

1.0

1.1

—

Lyme disease

1.84

0.73

1.0

1.1

—

Spirochaetal infections, other/unspecified

1.84

0.73

1.0

1.1

—

Other spirochaetal diseases

1.84

0.73

1.0

1.1

—

Other spirochaetal diseases

1.84

0.73

1.0

1.1

—

Other viral diseases

1.63

0.73

1.2

1.1

—

Inflammatory disease of uterus

2.00

0.72

1.0

—

Car occupant injured in other and unspecified transport accidents

2.00

0.72

1.0

1.1

—

Continuous positive airway pressure

2.01

0.72

1.0

1.1

—

Major coronary heart disease event

0.61

0.72

1.0

1.1

—

Infections with a predominantly sexual mode of transmission

1.62

0.71

1.0

—

Fracture at wrist and hand level

1.58

0.71

1.0

1.1

—

Finngen Rheumatological endpoints

119

1.34

0.69

1.0

1.1

—

Hyperlipidaemia, other/unspecified

1.70

0.69

1.0

1.1

—

Injuries to the wrist and hand

152

1.32

0.69

1.0

1.1

—

Coronary atherosclerosis

0.52

0.68

1.2

1.0

—

Fracture of rib(s), sternum and thoracic spine

1.85

0.68

1.0

1.1

—

Other viral diseases, not elsewhere classified

1.85

0.68

1.4

1.1

—

Syncope and collapse

1.65

0.68

1.0

1.1

—

Other obstetric conditions, not elsewhere classified

1.49

0.67

1.0

—

Other and unspecified tonsillitis

1.59

0.66

1.0

1.1

—

Other diseases of intestines

140

1.30

0.66

1.0

1.1

—

Diseases of the eye and adnexa

1.34

0.65

1.1

—

Visual disturbances and blindness

1.54

0.65

1.0

1.1

—

Viral infections characterized by skin and mucous membrane lesions

1.57

0.65

1.0

1.1

—

Embedded and impacted teeth

1.62

0.64

1.0

—

Disorders of skin appendages

1.47

0.63

1.0

1.1

—

Autoimmune diseases

144

0.74

0.62

1.0

1.1

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.66

0.62

1.0

—

Tooth eruption problems

1.68

0.62

1.0

1.1

—

Degenerative diseases of the nervous system

0.00

0.61

0.0

1.0

—

Hypothyroidism, other/unspecified

132

0.70

0.61

1.1

—

Calculus of kidney and ureter

1.67

0.61

1.0

1.1

—

Other degenerative diseases of the nervous system

0.00

0.61

0.0

1.0

—

Other viral diseases

1.51

0.60

1.2

1.1

—

Coronary artery bypass grafting

0.00

0.60

0.0

1.0

—

Thyrotoxicosis with diffuse goitre

0.00

0.60

0.0

1.0

—

Benign neoplasm of ovary

0.00

0.60

0.0

1.0

—

Hallux valgus (acquired)

1.80

0.59

1.0

—

Seborrhoeic keratosis

0.00

0.59

0.0

1.0

—

Gonarthrosis [arthrosis of knee](FG)

1.41

0.59

1.1

—

Delivery

0.55

0.59

1.0

—

Pneumonia, organism unspecified

138

0.71

0.57

1.1

1.0

—

Pain and other conditions associated with female genital organs and menstrual cycle

1.47

0.56

1.1

1.0

—

Other arthritis (FG)

1.67

0.56

1.2

1.1

—

Retinal detachments and breaks

1.67

0.56

1.0

—

Renal tubulo-interstitial diseases

129

0.69

0.56

1.0

—

Neurotic, stress-related and somatoform disorders

147

1.28

0.56

1.1

1.0

—

Persons encountering health services in other circumstances

1.50

0.55

1.1

—

Osteopathies and chondropathies

1.47

0.54

1.0

1.1

—

Anxiety disorders

147

1.28

0.54

1.1

1.0

—

Sulfasalazine

1.58

0.54

1.0

1.1

—

Glaucoma

1.49

0.54

1.0

—

Appendicitis, broad definition

144

1.32

0.54

1.1

—

Cholelithiasis

110

0.69

0.53

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

135

0.73

0.53

1.1

—

Diseases of the ear and mastoid process

137

1.25

0.53

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

122

1.30

0.52

1.0

1.1

—

Disorders of gallbladder, biliary tract and pancreas

129

0.73

0.51

1.1

—

Acute appendicitis

142

1.32

0.51

1.1

—

Diseases of appendix

145

1.31

0.51

1.1

—

Inflammatory diseases of female pelvic organs

105

1.33

0.50

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

129

0.76

0.49

1.0

1.1

—

Pain in throat and chest

102

1.30

0.48

1.0

1.1

—

Diabetes mellitus

138

0.76

0.48

1.0

1.1

—

Depression medications

0.60

0.48

1.0

1.1

—

Diseases of salivary glands

1.52

0.48

1.3

1.0

—

Irritable bowel syndrome

1.49

0.47

1.0

1.1

—

Used for control exclusion in common control thyroid runs

136

0.78

0.47

1.0

1.1

—

Ischaemic heart disease, wide definition

0.66

0.47

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.39

0.47

1.0

—

Cholelithiasis, broad definition with cholecystitis

112

0.72

0.47

1.1

—

Acute appendicitis, no complications

119

1.34

0.46

1.1

—

Systemic connective tissue disorders

1.46

0.46

1.1

1.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

104

0.67

0.46

1.1

1.0

—

Any event in cancer register

131

0.76

0.45

1.0

1.1

—

Visual disturbances

1.43

0.45

1.0

1.1

—

Other diseases of urinary system

125

0.76

0.45

1.1

—

Neoplasms

112

0.76

0.45

1.1

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

136

1.25

0.45

1.1

—

Insomnia

146

1.25

0.44

1.0

1.1

—

Diabetes, varying definitions

136

0.78

0.43

1.0

1.1

—

Certain infectious and parasitic diseases

109

1.24

0.43

1.0

1.1

—

Genitourinary diseases

0.71

0.43

1.2

1.1

—

Maternal care for other conditions predominantly related to pregnancy

1.43

0.42

1.0

—

Other heart diseases, wide

134

1.23

0.42

1.0

1.1

—

Alzheimer disease

0.00

0.42

0.0

1.0

—

Strabismus

1.56

0.42

1.4

1.0

—

Autoimmune diseases excluding thyroid diseases

144

0.80

0.42

1.0

1.1

—

Other diseases of lip and oral mucosa

1.38

0.41

1.0

1.1

—

Endometriosis ASRM stages 1,2

1.52

0.41

1.0

—

Acute alcohol intoxication

1.52

0.41

1.0

1.1

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

0.41

0.0

1.0

—

Uterine polyps

0.00

0.41

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.41

0.0

1.0

—

Malignant melanoma of skin, including Hilmo

0.00

0.41

0.0

1.0

—

Cystitis

110

0.76

0.41

1.1

—

Later onset COPD

0.00

0.41

0.0

1.0

—

ILD medications: azathioprine

0.00

0.41

0.0

1.0

—

Malignant neoplasm of colon, including Hilmo

0.00

0.41

0.0

1.0

—

Certain infectious and parasitic diseases

0.72

0.41

1.0

1.1

—

N06DA Anticholinesterases

0.00

0.41

0.0

1.0

—

Use of anticholinesterases

0.00

0.41

0.0

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

150

1.23

0.41

1.0

1.1

—

Oedema, not elsewhere classified

1.49

0.41

1.0

1.1

—

Female infertility, associated with anovulation

0.00

0.40

0.0

1.0

—

Insulin, fast-acting (human)

0.00

0.40

0.0

1.1

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.00

0.40

0.0

1.0

—

Congenital malformations and deformations of the musculoskeletal system

0.00

0.40

0.0

1.1

—

Other disorders of urethra and urinary system

101

1.29

0.40

1.0

—

Gonarthrosis, primary, with knee surgery

1.33

0.40

1.0

—

Atrophic disorders of skin

0.00

0.40

0.0

1.0

—

Congenital malformations and deformations of the musculoskeletal system

0.00

0.40

0.0

1.1

—

Other reaction to severe stress, and adjustment disorders

1.36

0.40

1.1

1.0

—

Pregnancy hypertension

0.66

0.39

1.1

1.0

—

Cutaneous abscess, furuncle and carbuncle

1.43

0.39

1.0

1.1

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

0.39

0.0

1.0

—

Schizophrenia

0.00

0.39

0.0

1.1

—

Functional dyspepsia

1.39

0.38

1.0

1.1

—

Other maternal disorders predominantly related to pregnancy

1.27

0.38

1.0

1.1

—

Oxycodone

1.37

0.37

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

142

0.81

0.37

1.0

1.1

—

Second line medication for Crohn's disease

112

0.71

0.37

1.0

1.1

—

Female infertility, cervical, vaginal, other or unspecified origin

0.64

0.36

1.0

—

Dyspnoea

132

1.23

0.36

1.0

1.1

—

Disorders of choroid and retina

1.31

0.35

1.0

1.1

—

Contact with and exposure to communicable diseases

0.65

0.35

1.4

1.1

—

All dysplastic lesions of the cervix uteri, vagina or vulva

0.65

0.35

1.0

—

Chronic periodontitis, including avohilmo

126

1.22

0.35

1.1

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.43

0.35

1.0

1.1

—

All kidney diseases

153

0.80

0.35

1.0

1.1

—

Postmenopausal bleeding

1.39

0.35

1.0

—

Periodontitis

126

1.22

0.35

1.1

1.0

—

Erosion of teeth , including avohilmo

1.40

0.35

1.0

1.1

—

Fracture of shoulder and upper arm

1.39

0.35

1.0

1.1

—

Abdominal and pelvic pain

108

1.21

0.35

1.0

1.1

—

Spinal stenosis

1.38

0.35

1.0

—

Single spontaneous delivery

0.66

0.34

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.35

0.34

1.0

1.1

—

Endometriosis

0.68

0.34

1.2

1.0

—

In situ neoplasms

1.33

0.33

1.0

—

Other disorders of eyelid

1.33

0.33

1.0

—

Menorrhagia

1.36

0.33

1.1

1.0

—

Persons with potential health hazards related to communicable diseases

0.69

0.33

1.3

1.1

—

Persons encountering health services for examination and investigation

1.34

0.33

1.0

1.1

—

Disorders of the thyroid gland

137

0.81

0.32

1.1

—

Pain (limb, back, neck, head abdominally)

1.27

0.32

1.0

1.1

—

Injuries to the head

151

1.18

0.32

1.1

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

127

0.80

0.32

1.1

—

Depression

148

1.19

0.32

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.35

0.31

1.0

1.1

—

Suppurative and unspecified otitis media

1.34

0.30

1.2

1.0

—

Acute bronchitis

1.32

0.30

1.0

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

0.71

0.30

1.0

1.1

—

Maternal care for known or suspected malpresentation of fetus

1.27

0.30

1.0

—

Personality disorders

1.27

0.30

1.0

1.1

—

Personality disorders, excluding more controls

1.27

0.30

1.0

1.1

—

Other abnormal products of conception

1.30

0.30

1.0

—

Sleep disorders

146

1.19

0.29

1.0

1.1

—

Sleep disorders (combined)

130

1.17

0.29

1.0

1.1

—

Hypothyroidism, strict autoimmune

115

0.80

0.29

1.1

—

Injuries to the thorax

1.25

0.29

1.0

1.1

—

Intestinal infectious diseases

154

1.18

0.29

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

124

1.19

0.28

1.0

1.1

—

Neurological diseases, wide definition

1.26

0.28

1.3

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1.30

0.28

1.0

—

Pregnancy with abortive outcome

0.80

0.27

1.1

1.0

—

Cholecystectomy

111

0.78

0.27

1.1

—

Hypothyroidism (congenital or acquired)

0.69

0.27

1.2

1.1

—

Maternal care for other known or suspected fetal problems

0.69

0.27

1.0

—

Gonarthrosis,primary

1.22

0.26

1.0

1.1

—

All chronic kidney diseases

0.68

0.26

1.2

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

134

1.21

0.26

1.0

—

Periapical abscess

0.68

0.26

1.0

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

0.68

0.26

1.0

1.1

—

Missing teeth due to accident, extraction or parodontitis

0.67

0.26

1.0

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

1.26

0.26

1.0

—

Other acute lower respiratory infections

1.28

0.26

1.0

1.1

—

Temporomandibular joint disorders, including avohilmo

1.26

0.25

1.0

—

Other retinal disorders

1.19

0.25

1.0

1.1

—

Female infertility

0.70

0.24

1.0

—

Mood [affective] disorders

152

1.15

0.24

1.0

1.1

—

Mood disorders

152

1.15

0.24

1.0

1.1

—

Unspecified mental disorder

0.72

0.24

1.0

1.1

—

Anti-inflammatory and antirheumatic products, non-steroids

1.32

0.24

1.0

—

False labour

1.27

0.23

1.3

1.0

—

Anxiety disorders, excluding more controls

129

1.16

0.23

1.1

1.0

—

Injury of muscle and tendon at shoulder and upper arm level

1.28

0.23

1.0

1.1

—

Chronic apical periodontitis

151

0.87

0.23

1.0

1.1

—

Varicose veins

0.75

0.23

1.0

—

Chronic periodontitis, complicated

1.27

0.22

1.0

1.1

—

Insulin medication

0.75

0.22

1.0

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

0.77

0.22

1.0

1.1

—

Nonsuppurative otitis media

1.24

0.22

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

151

0.86

0.22

1.1

—

Endometriosis of pelvic peritoneum

1.22

0.22

1.0

—

All pneumoniae

155

0.86

0.22

1.1

—

Myocardial infarction, unclassifiable

0.00

0.21

0.0

1.0

—

Specific development disorders of scholastic skills

0.00

0.21

0.0

1.2

—

Nonischemic cardiomyopathy

0.00

0.21

0.0

1.0

—

Inflammatory disease of cervix uteri

0.00

0.21

0.0

1.0

—

Mixed connective tissue disease

0.00

0.21

0.0

1.0

—

Autoimmune hyperthyroidism

0.00

0.21

0.0

1.0

—

Personal history of malignant neoplasm

0.00

0.21

0.0

1.0

—

Mental and behavioural disorders due to sedatives or hypnotics

0.00

0.21

0.0

1.2

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.00

0.21

0.0

1.2

—

Nontoxic single thyroid nodule

0.00

0.21

0.0

1.0

—

MS-disease / Multiple Sclerosis

0.00

0.21

0.0

1.0

—

Malignant neoplasm of corpus uteri

0.00

0.21

0.0

1.0

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

0.00

0.21

0.0

1.0

—

Inflammatory diseases of the central nervous system

0.00

0.21

0.0

1.0

—

Other and unspecified mood [affective] disorders

0.00

0.21

0.0

1.2

—

Melanocytic naevi, other sites/unspecified

0.00

0.21

0.0

1.0

—

Assault by bodily force

0.00

0.21

0.0

1.2

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.21

0.0

1.2

—

Bacterial, viral and other infectious agents

0.00

0.21

0.0

1.3

—

Use of disulfiram, acamprosate or naltrexone

0.00

0.21

0.0

1.0

—

Malignant neoplasm of corpus uteri, including Hilmo

0.00

0.21

0.0

1.0

—

Benign neoplasm: Cerebral meninges

0.00

0.21

0.0

1.0

—

Other diseases of arteries and capillaries

0.00

0.21

0.0

1.0

—

Type 1 diabetes, strict definition

0.00

0.21

0.0

1.2

—

Scoliosis

0.00

0.21

0.0

1.0

—

Bacterial, viral and other infectious agents

0.00

0.21

0.0

1.3

—

Benign neoplasm of meninges

0.00

0.21

0.0

1.0

—

Other benign neoplasms of connective and other soft tissue

0.00

0.21

0.0

1.0

—

Weight loss

0.00

0.21

0.0

1.0

—

Perforation of tympanic membrane

0.00

0.21

0.0

1.0

—

Enterocolitis due to Clostridium difficile

0.00

0.21

0.0

1.0

—

Symptoms and signs concerning food and fluid intake

0.00

0.21

0.0

1.0

—

Abnormalities of gait and mobility

0.00

0.21

0.0

1.0

—

Nephropathy related operations

0.00

0.21

0.0

1.0

—

Diseases of the myoneural junction and muscle

0.00

0.21

0.0

1.2

—

Chronic pancreatitis

0.00

0.21

0.0

1.0

—

Dialysis, with operation codes

0.00

0.21

0.0

1.0

—

Parkinson's disease

0.00

0.21

0.0

1.0

—

Parkinson's disease, including avohilmo

0.00

0.21

0.0

1.0

—

ILD, hospital admissions

0.00

0.21

0.0

1.0

—

Malignant neoplasm of colon

0.00

0.21

0.0

1.0

—

Other interstitial pulmonary diseases

0.00

0.21

0.0

1.0

—

Interstitial lung disease endpoints

0.00

0.21

0.0

1.0

—

Interstitial lung disease

0.00

0.21

0.0

1.0

—

Pleural effusion

0.00

0.21

0.0

1.0

—

Peripheral arterial reconstruction

0.00

0.21

0.0

1.0

—

DVT of lower extremities and pulmonary embolism

1.19

0.21

1.0

—

Ovarian dysfunction

0.00

0.21

0.0

1.0

—

Glomerulonephritis

0.00

0.21

0.0

1.2

—

Lichen sclerosus et atrophicus

0.00

0.21

0.0

1.0

—

Other and unspecified visual disturbances

0.00

0.21

0.0

1.0

—

Transplanted organ and tissue status

0.00

0.21

0.0

1.2

—

Hydronephrosis

0.00

0.21

0.0

1.0

—

Cardiomyopathies, Primary/intrinsic

0.00

0.21

0.0

1.0

—

Cardiomyopathy (excluding other)

0.00

0.21

0.0

1.0

—

Non-Hodgkin lymphoma, all, including Hilmo

0.00

0.21

0.0

1.0

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

0.00

0.21

0.0

1.2

—

Any mental disorder

132

0.87

0.21

1.1

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

155

0.87

0.21

1.1

—

L04AX Other immunosuppressants

105

0.76

0.21

1.0

1.1

—

Disorders of optic nerve and visual pathways

0.00

0.21

0.0

1.0

—

Other noninflammatory disorders of vulva and perineum

0.00

0.21

0.0

1.0

—

Graves disease, strict definition

0.00

0.21

0.0

1.0

—

Pain associated with micturition

0.00

0.21

0.0

1.0

—

Melanocytic naevi of trunk

0.00

0.21

0.0

1.2

—

Other disorders of kidney and ureter

0.00

0.21

0.0

1.0

—

Social phobias

0.00

0.21

0.0

1.0

—

Misadventures to patients during surgical and medical care

0.00

0.21

0.0

1.0

—

Type 1 diabetes, strict (exclude DM2)

0.00

0.21

0.0

1.2

—

Type 1 diabetes, definitions combined

0.00

0.21

0.0

1.2

—

Congenital malformations of genital organs

0.00

0.20

0.0

1.0

—

Autoimmune diseases related-to ILD

156

1.15

0.20

1.0

1.1

—

Crossbite

0.00

0.20

0.0

1.0

—

Viral warts

0.00

0.20

0.0

1.1

—

Problems related to lifestyle

0.00

0.20

0.0

1.1

—

Other disorders of the musculoskeletal system and connective tissue

0.00

0.20

0.0

1.0

—

Azathioprine

0.00

0.20

0.0

1.0

—

Disorders of refraction and accommodation

1.25

0.20

1.0

—

Dental caries

1.23

0.20

1.0

1.1

—

Septicaemia

1.22

0.20

1.0

1.1

—

Disorders of breast

1.20

0.20

1.0

1.1

—

Other diseases of hard tissues of teeth

0.81

0.19

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

131

1.17

0.19

1.0

—

Abnormal findings on diagnostic imaging of lung

1.17

0.19

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.21

0.19

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

143

1.16

0.19

1.0

1.1

—

Psychiatric diseases

115

0.87

0.19

1.1

1.0

—

Excessive, frequent and irregular menstruation

1.22

0.18

1.0

—

Diseases of the musculoskeletal system and connective tissue

1.21

0.18

1.2

1.0

—

Benign neoplasm: Colon

1.21

0.18

1.0

—

Fracture of forearm

1.21

0.18

1.0

1.1

—

Pregnancy, childbirth and the puerperium

1.14

0.18

1.0

—

Neurological diseases

1.14

0.18

1.0

1.1

—

Cerebrovascular diseases

1.20

0.17

1.3

1.1

—

Other menopausal disorders

1.13

0.17

1.0

—

Care involving use of rehabilitation procedures

1.23

0.17

1.0

—

Hypothyroidism, levothyroxine purchases

0.71

0.17

1.2

1.1

—

Hypothyroidism and >3 levothyroxin purchases

0.71

0.17

1.2

1.1

—

Antenatal screening

0.70

0.17

1.0

—

Long labour

0.74

0.17

1.0

—

Other bacterial diseases

124

0.87

0.17

1.1

1.0

—

Symptoms and signs involving the urinary system

100

0.84

0.17

1.0

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

0.75

0.17

1.0

1.1

—

Persons encountering health services in circumstances related to reproduction

1.16

0.16

1.1

1.0

—

Dentofacial anomalies [including malocclusion]

134

1.14

0.16

1.0

1.1

—

Hypertension

104

0.87

0.16

1.0

1.1

—

Hypertensive diseases

104

0.87

0.16

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.12

0.16

1.0

1.1

—

Labour and delivery complicated by fetal stress [distress]

1.21

0.15

1.1

1.0

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

0.85

0.15

1.0

1.1

—

Malignant neoplasm of breast, HER2-negative

0.80

0.15

1.0

—

Inguinal hernia

0.78

0.15

1.0

1.1

—

Malignant neoplasm of breast

0.77

0.15

1.0

1.1

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

0.77

0.14

1.0

1.1

—

Malignant neoplasm of breast, including Hilmo

0.77

0.14

1.0

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

138

1.10

0.14

1.0

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.19

0.14

1.2

1.0

—

Noninfective enteritis and colitis

1.08

0.14

1.0

1.1

—

Alcohol use disorder, Swedish definition

0.78

0.14

1.0

1.1

—

Endocrine, nutritional and metabolic diseases

100

1.11

0.13

1.0

1.1

—

Noninflammatory disorders of female genital tract

1.17

0.13

1.0

—

Heart failure, not strict

0.84

0.13

1.1

—

Other disorders of ear

111

1.12

0.13

1.1

—

Cardiovascular diseases

1.12

0.13

1.0

1.1

—

Erysipelas

1.15

0.13

1.2

1.0

—

Other (not insulin) diabetes medications

118

1.11

0.12

1.0

1.1

—

Ischemic heart diseases

0.88

0.12

1.1

—

Gestational diabetes (for exclusion)

0.86

0.12

1.0

—

Benign neoplasms

126

1.09

0.11

1.1

1.0

—

Implicit Sepsis

1.13

0.11

1.0

1.1

—

Complications of labour and delivery

0.88

0.11

1.1

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

143

1.09

0.11

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

115

1.10

0.10

1.0

1.1

—

STROKE

1.15

0.10

1.1

—

Statin medication

0.90

0.10

1.0

1.1

—

Coxarthrosis, primary, with hip surgery

1.14

0.10

1.0

—

Constipation

113

1.10

0.10

1.0

1.1

—

Non-selective monoamine reuptake inhibitors

1.07

0.09

1.0

—

Necrosis of pulp, including avohilmo

124

0.88

0.09

1.1

—

Type 2 diabetes, wide definition

1.12

0.09

1.1

—

Melanocytic naevi

1.04

0.09

1.0

1.1

—

Other benign neoplasms of skin

1.04

0.09

1.0

1.1

—

Ischaemic Stroke, excluding all haemorrhages

1.12

0.09

1.2

1.0

—

Biguanides

112

1.09

0.08

1.1

—

Diseases of oral cavity, salivary glands and jaws

0.88

0.08

1.2

1.1

—

Obstructed labour due to malposition and malpresentation of fetus

1.06

0.08

1.3

1.0

—

Depression or dysthymia

1.10

0.08

1.1

1.0

—

Supervision of high-risk pregnancy

0.79

0.08

1.2

1.0

—

Polyp of the female genital tract

0.78

0.08

1.0

—

Benzodiazepine use

156

0.93

0.08

1.0

1.1

—

Atrial fibrillation and flutter

1.11

0.08

1.0

1.1

—

Medical abortion

1.10

0.08

1.1

1.0

—

Disorders of adult personality and behaviour

0.83

0.08

1.0

1.1

—

Stroke, excluding SAH

1.09

0.08

1.1

1.0

—

Venous thromboembolism

1.04

0.08

1.0

1.1

—

Hypertension, essential

1.09

0.08

1.0

1.1

—

Diseases of arteries, arterioles and capillaries

0.81

0.07

1.0

1.1

—

Haemorrhage in early pregnancy

1.02

0.07

1.0

—

Type 2 diabetes

126

0.93

0.07

1.1

—

Stroke, including SAH

1.09

0.07

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

124

0.93

0.07

1.1

—

Irregular menses

105

0.90

0.07

1.1

1.0

—

Erysipelas

1.04

0.07

1.1

—

Senile cataract

0.82

0.07

1.0

—

Diseases of male genital organs

1.06

0.07

1.2

1.1

—

Other anxiety disorders

102

1.10

0.07

1.2

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

105

0.90

0.07

1.0

—

Mental and behavioural disorders due to alcohol

1.05

0.07

1.0

1.1

—

Disorders of lens

0.86

0.07

1.0

1.1

—

Contraceptive management

1.12

0.06

1.3

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

107

1.07

0.06

1.0

1.1

—

Polyarthropathies

1.10

0.06

1.1

—

Conductive and sensorineural hearing loss

0.87

0.06

1.0

1.1

—

Substance abuse, excluding more controls

0.86

0.06

1.2

1.0

—

Substance abuse

0.85

0.06

1.2

1.1

—

Mood disorders, excluding more controls

129

1.06

0.06

1.0

—

Diseases of middle ear and mastoid

105

1.09

0.06

1.1

1.0

—

Viral infections characterized by skin and mucous membrane lesions

160

1.07

0.06

1.0

1.1

—

Selective serotonin reuptake inhibitors

118

1.06

0.06

1.0

1.1

—

Any reimbursement code in KELA

1.08

0.05

1.1

—

Antihypertensive medication - note that there are other indications

1.07

0.05

1.0

1.1

—

Other heart diseases

0.91

0.05

1.0

1.1

—

Diabetes medication

137

0.95

0.04

1.0

1.1

—

Mental and behavioural disorders due to psychoactive substance use

101

0.92

0.04

1.2

1.1

—

Other bacterial diseases

139

1.05

0.04

1.1

—

Type 2 diabetes, strict (exclude DM1)

117

1.05

0.04

1.0

1.1

—

Type 2 diabetes, definitions combined

117

1.05

0.04

1.0

1.1

—

GASTRO-related operations

1.06

0.03

1.1

—

Any gastric operation

1.06

0.03

1.1

—

Parasetamol

1.06

0.03

1.0

1.1

—

Implicit Sepsis

110

1.06

0.03

1.0

1.1

—

Leiomyoma of uterus

0.93

0.03

1.2

1.0

—

Hypertensive diseases (excluding secondary)

1.07

0.03

1.0

1.1

—

Dental caries, including avohilmo

1.07

0.03

1.1

1.0

—

Hard cardiovascular diseases

1.06

0.03

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

120

0.95

0.03

1.1

—

Other antidepressants

118

1.04

0.02

1.0

1.1

—

Caries of dentine, including avohilmo

0.94

0.02

1.1

1.0

—

Acute tubulo-interstitial nephritis

0.93

0.02

1.0

—

Diabetes mellitus in pregnancy

0.93

0.02

1.0

1.1

—

Disease of hard tissues of teeth, NOS

1.06

0.02

1.0

1.1

—

Gastrointestinal diseases

0.95

0.01

1.1

—

Hernia

129

1.04

0.01

1.1

—

0.94

0.01

1.0

1.1

—

111

1.04

0.01

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

111

1.04

0.01

1.1

—

Anxiety (asthma-related co-morbidities)

119

1.04

0.00

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

110

0.97

0.00

1.0

1.1

—

Dermatophytosis

109

1.01

0.00

1.2

1.0

—

Other disorders of skin and subcutaneous tissue

100

0.98

0.00

1.0

1.1

—

1.03

0.00

1.0

1.1

—

Reimbursement for rheumatic diseases

1.03

0.00

1.1

—

Dental operations

1.03

0.00

1.2

1.1

—

All anxiety disorders

125

1.01

0.00

1.1

—

Use of hypnotics and sedatives

130

1.02

0.00

1.0

1.1

—

Symptoms and signs involving the digestive system and abdomen

108

1.02

0.00

1.0

1.1

—

ILD medications: immunosuppressive drugs

0.97

0.00

1.0

—

Bleeding

0.99

0.00

1.0

1.1

—

Diseases of pulp and periapical tissues and dental caries

1.01

0.00

1.2

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

116

1.00

0.00

1.1

—

Persons encountering health services in other circumstances, wide

138

1.01

0.00

1.0

1.1

—

Gingivitis and periodontal diseases

113

1.00

0.00

1.1

—

Influenza and pneumonia

159

1.00

0.00

1.0

1.1

—

Other obstructive and reflux uropathy

0.00

0.0

1.0

—

Benign neoplasm of middle ear and respiratory system

0.00

0.0

1.0

—

Tobacco use

0.00

0.0

1.0

—

ILD, hospital admissions 1, main diag only

0.00

0.0

1.0

—

Scar conditions and fibrosis of skin

0.00

0.0

1.0

—

Algoneurodystrophy

0.00

0.0

1.0

—

Male infertility

0.00

0.0

1.0

—

Non-small cell lung cancer

0.00

0.0

1.0

—

Alzheimer disease, excluding more controls

0.00

0.0

1.0

—

Benign neoplasm: Skin of lower limb, including hip

0.00

0.0

1.0

—

Schizophrenia or delusion

0.85

0.00

1.0

1.1

—

Unspecified misadventure during surgical and medical care

0.00

0.0

1.0

—

Vestibular neuronitis

0.00

0.0

1.0

—

Ulcerative enterocolitis

0.00

0.0

1.0

—

Abnormal weight loss

0.00

0.0

1.0

—

Use of biperiden

0.00

0.0

1.0

—

Total colectomy

0.00

0.0

1.0

—

Biomechanical lesions, not elsewhere classified

0.00

0.0

1.0

—

Gestational [pregnancy-induced] hypertension

0.87

0.00

1.2

1.0

—

Total colectomy operation

0.00

0.0

1.0

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

0.0

1.0

—

Bacterial pneumonia (organism specified)

0.94

0.00

1.0

1.1

—

Other Crohn's disease

0.00

0.0

1.3

—

Other disorders of pigmentation

0.00

0.0

1.0

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

0.00

0.0

1.0

—

Oesophagitis

0.00

0.0

1.0

—

Bacterial infection, other or unspecified

0.91

0.00

1.0

1.1

—

Peripheral retinal degeneration

0.00

0.0

1.0

—

Malignant neoplasm of urinary organs

0.00

0.0

1.0

—

Other infective otitis externa

0.00

0.0

1.0

—

Convergent concomitant strabismus

0.00

0.0

1.0

—

Benign neoplasm: Long bones of lower limb

0.00

0.0

1.0

—

Anankastic personality disorder

0.00

0.0

1.0

—

Emphysema

0.00

0.0

1.0

—

Urethritis and urethral syndrome

0.00

0.0

1.0

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

0.0

1.0

—

Other noninfective disorders of lymphatic vessels and lymph nodes

0.00

0.0

1.0

—

Other diseases of stomach and duodenum

0.00

0.0

1.0

—

Abnormal findings on examination of urine, without diagnosis

0.00

0.0

1.0

—

Left bundle-branch block

0.00

0.0

1.0

—

Dilated cardiomyopathy

0.00

0.0

1.0

—

Other salmonella infections

0.00

0.0

1.0

—

Other salmonella infections

0.00

0.0

1.0

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

0.00

-0.00

0.0

1.0

—

Cholangitis (primary sclerosing, PSC)

0.00

-0.00

0.0

1.0

—

Mental retardation, excluding more controls

0.00

-0.00

0.0

1.0

—

COPD-related respiratory insufficiency

0.00

-0.00

0.0

1.0

—

Alcohol use disorder, ICD-based

0.89

-0.00

1.0

1.1

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

0.00

-0.00

0.0

1.0

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

0.00

-0.00

0.0

1.0

—

Mental and behavioural disorders due to opioids

0.00

-0.00

0.0

1.3

—

Chronic ulcer of skin, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Tuberculosis, IBD comorbidity

0.00

-0.00

0.0

1.0

—

Crohn disease (strict definition, require KELA, min 2 HDR)

0.00

-0.00

0.0

1.2

—

Sleep disorders, other/unspecified

0.00

-0.00

0.0

1.0

—

Congenital malformations of the urinary system

0.00

-0.00

0.0

1.0

—

Volume depletion

0.00

-0.00

0.0

1.0

—

Intestinal adhesions without obstruction

0.00

-0.00

0.0

1.0

—

UC patients in KELA-register (code 208), prior to 1994

0.00

-0.00

0.0

1.0

—

Schizophrenia or delusion, excluding more controls

0.85

-0.00

1.0

1.1

—

Benign neoplasm: Caecum

0.00

-0.00

0.0

1.0

—

Wide developmental disorders

0.00

-0.00

0.0

1.3

—

Cyst of Bartholin Gland

0.00

-0.00

0.0

1.0

—

Unspecified abortion

0.00

-0.00

0.0

1.0

—

Follow-up examination after treatment for malignant neoplasms

0.00

-0.00

0.0

1.0

—

Other juvenile arthritis

0.00

-0.00

0.0

1.3

—

Visual field defects

0.00

-0.00

0.0

1.0

—

Giant cell arteritis

0.00

-0.00

0.0

1.0

—

Tooth agenesis EXCLUDE clefts and syndromes

0.00

-0.00

0.0

1.0

—

Agoraphobia

0.00

-0.00

0.0

1.0

—

Right hemicolectomy

0.00

-0.00

0.0

1.0

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

-0.00

0.0

1.4

—

Osteonecrosis

0.00

-0.00

0.0

1.0

—

Postprocedural musculoskeletal disorders, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Other and unspecified injuries of ankle and foot

0.00

-0.00

0.0

1.0

—

Chronic tubulo-interstitial nephritis

0.00

-0.00

0.0

1.0

—

Hydrocephalus

0.00

-0.00

0.0

1.0

—

Other disorders of binocular movement

0.00

-0.00

0.0

1.0

—

Undefined dementia

0.00

-0.00

0.0

1.0

—

Fibrosis and cirrhosis of liver

0.00

-0.00

0.0

1.0

—

Other disorders of nervous system

0.00

-0.00

0.0

1.0

—

Bacterial pneumoniae

0.94

-0.00

1.0

1.1

—

Chronic nephritic syndrome

0.00

-0.00

0.0

1.0

—

Colon adenocarcinoma

0.00

-0.00

0.0

1.0

—

Multiple myeloma, including Hilmo

0.00

-0.00

0.0

1.0

—

Brain meningioma, including Hilmo

0.00

-0.00

0.0

1.0

—

Idiopathic gout

0.00

-0.00

0.0

1.0

—

Other disorders of adrenal gland

0.00

-0.00

0.0

1.0

—

Idiopathic pulmonary fibrosis

0.00

-0.00

0.0

1.0

—

Congenital malformations of the urinary system

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

0.00

-0.00

0.0

1.0

—

Other or ill-defined heart diseases

0.00

-0.00

0.0

1.3

—

Benign neoplasm of brain and other parts of central nervous system

0.00

-0.00

0.0

1.0

—

Bacterial infection, other or unspecified

0.92

-0.00

1.0

1.1

—

Delivery, wide proxy

0.93

-0.00

1.0

—

Labour and delivery complicated by umbilical cord complications

0.00

-0.00

0.0

1.0

—

Crohn's disease NAS

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of stomach, including Hilmo

0.00

-0.00

0.0

1.0

—

Immunodeficiency with predominantly antibody defects

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of pancreas, including Hilmo

0.00

-0.00

0.0

1.0

—

Immunodeficiencies

0.00

-0.00

0.0

1.0

—

Open bite

0.00

-0.00

0.0

1.0

—

Tubulo-interstitial nephritis, not specified as acute or chronic

0.00

-0.00

0.0

1.0

—

Excessive earwax

0.94

-0.00

1.0

1.1

—

Other diseases of pericardium

0.00

-0.00

0.0

1.0

—

Use of galantamine

0.00

-0.00

0.0

1.0

—

Hypercalcemia

0.00

-0.00

0.0

1.0

—

Crohn's disease of small intestine

0.00

-0.00

0.0

1.3

—

Kidney transplant status

0.00

-0.00

0.0

1.0

—

Follicular lymphoma, hilmo

0.00

-0.00

0.0

1.0

—

Procreative management

1.00

-0.00

1.0

—

Laparoscopic right hemicolectomy

0.00

-0.00

0.0

1.0

—

Atrial septal defect

0.00

-0.00

0.0

1.0

—

Cyst of kidney

0.00

-0.00

0.0

1.0

—

Congenital ovarian cysts

0.00

-0.00

0.0

1.0

—

Left ventricular outflow tract obstruction, narrow definition

0.00

-0.00

0.0

1.0

—

Use of levodopa decarboxylase inhibitor

0.00

-0.00

0.0

1.0

—

Maternal care for cervical incompetence

0.00

-0.00

0.0

1.0

—

Congenital deformities of feet

0.00

-0.00

0.0

1.0

—

Abnormal findings on diagnostic imaging of central nervous system

0.00

-0.00

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

-0.00

0.0

1.0

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

0.00

-0.00

0.0

1.0

—

L01XE Protein kinase inhibitors

0.00

-0.00

0.0

1.0

—

Hypoparathyroidism

0.00

-0.00

0.0

1.0

—

Unspecified dementia

0.00

-0.00

0.0

1.0

—

Benign neoplasm of other and unspecified female genital organs

0.00

-0.00

0.0

1.0

—

Perineal laceration during delivery

0.97

-0.00

1.0

—

Medicines for HER+ breast cancer

1.01

-0.00

1.0

—

Otosclerosis

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

-0.00

0.0

1.0

—

Other general symptoms and signs

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Liver/bile ducts

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Transverse colon

0.00

-0.00

0.0

1.0

—

Bacterial meningitis

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.00

-0.00

0.0

1.0

—

Mixed conductive and sensorineural hearing loss

0.00

-0.00

0.0

1.0

—

Generalized epilepsy

0.00

-0.00

0.0

1.0

—

Pyogenic arthritis

0.00

-0.00

0.0

1.0

—

Disturbances of smell and taste

0.00

-0.00

0.0

1.0

—

Other/unspecified disorders of vestibular function

0.00

-0.00

0.0

1.0

—

Other symptoms and signs involving the urinary system

0.00

-0.00

0.0

1.0

—

Squamous cell neoplasms and carcinomas of the skin

0.00

-0.00

0.0

1.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

0.00

-0.00

0.0

1.0

—

Other and unspecified myopathies

0.00

-0.00

0.0

1.0

—

Thyrotoxicosis with toxic multinodular goitre

0.00

-0.00

0.0

1.0

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

0.00

-0.00

0.0

1.0

—

Other symptoms and signs involving cognitive functions and awareness

1.01

-0.00

1.0

1.1

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

-0.00

0.0

1.2

—

Other specified/unspecified systemic involvement of connective tissue

0.00

-0.00

0.0

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

0.91

-0.00

1.0

1.1

—

Malignant melanoma of skin

0.00

-0.00

0.0

1.0

—

Ill-defined and unknown causes of mortality

0.00

-0.00

0.0

1.0

—

Vitamin B12 deficiency anaemia

0.00

-0.00

0.0

1.0

—

Speech disturbances, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of bladder, including Hilmo

0.00

-0.00

0.0

1.0

—

Hypoplasia of dental enamel , including avohilmo

0.00

-0.00

0.0

1.0

—

Other and unspecified mononeuropathies, also in other diseases

0.00

-0.00

0.0

1.0

—

Secondary hypertension

0.00

-0.00

0.0

1.3

—

Congenital iodine-deficiency syndrome/hypothyroidism

0.00

-0.00

0.0

1.0

—

Presbycusis

0.00

-0.00

0.0

1.0

—

Adrenocortical insufficiency

0.00

-0.00

0.0

1.0

—

Entropion and trichiasis of eyelid

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of pancreas

0.00

-0.00

0.0

1.0

—

Ulcerative ileocolitis

0.00

-0.00

0.0

1.3

—

Hidradenitis suppurativa

0.00

-0.00

0.0

1.0

—

Type1 diabetes, definitions combined, early onset

0.00

-0.00

0.0

1.3

—

Glaucoma, exfoliation

0.00

-0.00

0.0

1.0

—

Chronic iridocyclitis

0.00

-0.00

0.0

1.0

—

Foreign body in alimentary tract

0.00

-0.00

0.0

1.0

—

Toxic effect of ethanol

0.00

-0.00

0.0

1.0

—

Pediculosis, acariasis and other infestations

0.00

-0.00

0.0

1.0

—

Tongue abnormality

0.00

-0.00

0.0

1.0

—

Brain meningioma

0.00

-0.00

0.0

1.0

—

Use of donepezil

0.00

-0.00

0.0

1.0

—

Open wound of head

1.00

-0.00

1.0

—

Autism

0.00

-0.00

0.0

1.0

—

Extracorporeal dialysis

0.00

-0.00

0.0

1.0

—

Disorders of orbit

0.00

-0.00

0.0

1.0

—

Injuries involving multiple body regions

0.00

-0.00

0.0

1.0

—

Other disorders of optic [2nd] nerve and visual pathways

0.00

-0.00

0.0

1.0

—

Disorders of calcium metabolism

0.00

-0.00

0.0

1.0

—

Crohn disease (strict definition, all UC cases excluded)

0.00

-0.00

0.0

1.0

—

Varicose veins of other sites

0.00

-0.00

0.0

1.3

—

Autism spe, excluding more controls

0.00

-0.00

0.0

1.0

—

Use of rivastigmine

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of breast, HER-positive

0.91

-0.00

1.0

—

Duodenal ulcer

0.00

-0.00

0.0

1.0

—

Sensorineural hearing loss

0.94

-0.00

1.0

1.1

—

Other mental disorders due to brain damage and dysfunction and to physical disease

0.00

-0.00

0.0

1.0

—

Optic neuritis

0.00

-0.00

0.0

1.0

—

Polycystic ovarian syndrome

0.00

-0.00

0.0

1.0

—

Non-follicular lymphoma

0.00

-0.00

0.0

1.0

—

Pregnancy examination and test

0.94

-0.00

1.0

—

ILD, hospital admission 2, with pulmonary infections

0.00

-0.00

0.0

1.0

—

Need for other prophylactic measures

0.00

-0.00

0.0

1.0

—

ILD, hospital admissions 3, with pneumonia sepsis

0.00

-0.00

0.0

1.0

—

Helminthiases

0.00

-0.00

0.0

1.0

—

Parkinson's disease, strict definition

0.00

-0.00

0.0

1.0

—

Abnormal spermatozoa

0.00

-0.00

0.0

1.0

—

Other necrotizing vasculopathies

0.00

-0.00

0.0

1.0

—

Autism spe

0.00

-0.00

0.0

1.0

—

Scabies

0.00

-0.00

0.0

1.0

—

Special screening examination for neoplasms

0.00

-0.00

0.0

1.0

—

Parkinson's disease, strict definition, excluding more controls

0.00

-0.00

0.0

1.0

—

Carrier of infectious disease

0.00

-0.00

0.0

1.0

—

Later onset COPD, excluding more controls

0.00

-0.00

0.0

1.0

—

Wide developmental disorders, excluding more controls

0.00

-0.00

0.0

1.0

—

Mental retardation

0.00

-0.00

0.0

1.0

—

Parkinson's disease, excluding more controls

0.00

-0.00

0.0

1.0

—

Care involving dialysis

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of kidney, except renal pelvis

0.00

-0.00

0.0

1.0

—

Maltreatment syndromes

0.00

-0.00

0.0

1.3

—

Juvenile arthritis (FINNGEN)

0.00

-0.00

0.0

1.3

—

Other acquired deformities of musculoskeletal system and connective tissue

0.00

-0.00

0.0

1.0

—

Other disorders of bone density and structure

0.00

-0.00

0.0

1.0

—

Crohn disease (strict definition, require KELA)

0.00

-0.00

0.0

1.2

—

Delirium, not induced by alcohol and other psychoactive substances

0.00

-0.00

0.0

1.0

—

Ascites

0.00

-0.00

0.0

1.0

—

Meningitis

0.00

-0.00

0.0

1.0

—

Systemic lupus erythematosus

0.00

-0.00

0.0

1.0

—

Schizophrenia, schizotypal and delusional disorders

0.86

-0.00

1.0

1.1

—

Benign neoplasm: Descending colon

0.00

-0.00

0.0

1.0

—

0.00

-0.00

0.0

1.0

—

Lesion of radial nerve

0.00

-0.00

0.0

1.0

—

Chondromalacia

0.00

-0.00

0.0

1.0

—

Tuberculosis, wide

0.00

-0.00

0.0

1.0

—

Abnormal blood-pressure reading, without diagnosis

0.00

-0.00

0.0

1.0

—

Disorders of other endocrine glands

0.93

-0.00

1.0

1.1

—

Conductive hearing loss, unspecified

0.00

-0.00

0.0

1.0

—

Disorder of external ear, unspecified

0.00

-0.00

0.0

1.0

—

Glaucoma-related operations

0.00

-0.00

0.0

1.0

—

Molar incisor enamel hypoplasia

0.00

-0.00

0.0

1.0

—

Intermittent heterotropia

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of breast, ER-positive, including Hilmo

0.88

-0.00

1.0

—

Ovarian cyst

0.96

-0.00

1.0

—

Insulin, intermediate and long-acting

0.94

-0.00

1.0

1.1

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

0.00

-0.00

0.0

1.0

—

Memory loss

0.00

-0.00

0.0

1.0

—

Mental retardation, wide definition

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS